These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 620483)

  • 1. Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.
    Wingard LB; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1978 Feb; 23(2):212-7. PubMed ID: 620483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients.
    McAleer SD; Foondun AS; Feely M; Chrystyn H
    Chirality; 1997; 9(1):13-6. PubMed ID: 9094197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.
    Toon S; Hopkins KJ; Garstang FM; Rowland M
    Eur J Clin Pharmacol; 1987; 32(2):165-72. PubMed ID: 3582481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of coumarin anticoagulants XXIX: Elimination kinetics and anticoagulant activity of (S)-(-)-warfarin in rats before and after chronic administration.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1275-7. PubMed ID: 903865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of coumarin anticoagulants XXXV: Examination of possible pharmacokinetic interaction between (R)-(+)- and (S)-(--)-warfarin in humans.
    Levy G; O'Reilly RA; Wingard LB
    J Pharm Sci; 1978 Jun; 67(6):867-8. PubMed ID: 660478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
    Zhou Q; Chan E
    Eur J Pharm Sci; 2002 Oct; 17(1-2):73-80. PubMed ID: 12356422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of terodiline on anticoagulation effect of warfarin and steady-state plasma levels of warfarin enantiomers in healthy volunteers.
    Höglund P; Paulsen O; Bogentoft S
    Ther Drug Monit; 1989 Nov; 11(6):667-73. PubMed ID: 2595747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomers of warfarin and vitamin K1 metabolism.
    Choonara IA; Haynes BP; Cholerton S; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1986 Dec; 22(6):729-32. PubMed ID: 3567019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stereoselective interaction of warfarin and metronidazole in man.
    O'Reilly RA
    N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin.
    Matsumoto K; Ishida S; Ueno K; Hashimoto H; Takada M; Tanaka K; Kamakura S; Miyatake K; Shibakawa M
    J Clin Pharmacol; 2001 Apr; 41(4):459-64. PubMed ID: 11304904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.
    Chan E; McLachlan A; O'Reilly R; Rowland M
    Clin Pharmacol Ther; 1994 Sep; 56(3):286-94. PubMed ID: 7924124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.
    Breckenridge AM; Cholerton S; Hart JA; Park BK; Scott AK
    Br J Pharmacol; 1985 Jan; 84(1):81-91. PubMed ID: 3978316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.
    Toon S; Holt BL; Mullins FG; Bullingham R; Aarons L; Rowland M
    Br J Clin Pharmacol; 1990 Nov; 30(5):743-50. PubMed ID: 2271374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses.
    Kobayashi S; Ishii K; Yamada Y; Ryu E; Hashizume J; Nose S; Hara T; Nakashima M; Ohyama K
    J Thromb Thrombolysis; 2019 Apr; 47(3):467-472. PubMed ID: 30465164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.